Health Press Release – Newsletter for January 13, 2011

Financial Fear of the Dentist Worse Than the Drill

LONDON, January 12, 2011 – It used to be a fear of the dentist that kept us away from the dental
chair but today it is more than twice as likely to be the cost of dental care
that's holding us back, according to research from Tesco Dental Insurance
(www.tescofinance.com/personal/finance/insurance/dentalins/index.jsp).

Over a third of …. Read the original article  : Financial Fear of the Dentist Worse Than the Drill.

Revolutionary Treatment Tops ME/ CFS Poll

LONDON, January 12, 2011 – A revolutionary self training course has emerged top in a survey
conducted by the Sussex and Kent ME/ CFS Society.

In a poll of 457 members, tracking their experiences over two years, 44
per cent of the society's members found the Lightning Process "very helpful"
and 36 per cent … Read more »»».

FDA Agrees to Special Protocol Assessment (SPA) to Evaluate the Safety and Efficacy of a Fixed-Dose Combination (FDC) of Netupitant and Palonosetron in the Prevention of CINV

LUGANO, Switzerland and WOODCLIFF LAKE, New Jersey, January 12, 2011 – Helsinn Group and Eisai Inc. announced today that the U.S.
Food and Drug Administration (FDA) has agreed to the safety and efficacy
protocols for Phase III trials with an investigational oral fixed-dose
combination of netupitant and palonosetron in the prevention of
chemotherapy-induced nausea and vomiting (CINV).

…. Source  : Gaea News Network.

Daiichi Sankyo and ArQule Enroll First Non-Small Cell Lung Cancer Patient Into Global Phase III Trial for ARQ 197

TOKYO and WOBURN, Massachusetts, January 12, 2011 – Daiichi Sankyo Company, Limited (TSE 4568) and ArQule, Inc. (Nasdaq:
ARQL) today announced that the first patient has been enrolled in the phase
III trial of ARQ 197, an investigational selective inhibitor of the c-Met
receptor tyrosine kinase, in combination with erlotinib, for patients
diagnosed with non-squamous, non-small cell lung …. Original article  : Daiichi Sankyo and ArQule Enroll First Non-Small Cell Lung Cancer Patient Into Global Phase III Trial for ARQ 197.

St. Andrews Country Club of Boca Raton Members Team With Morgan Pressel to Raise $502,000 to Fight Breast Cancer

BOCA RATON, Florida, January 12, 2011 – The Kathryn Krickstein Pressel MammoVan
(www.lpga.com/content_1.aspx?pid=26137&mid=2) purchased in 2009
through fundraising efforts of St. Andrews Country Club members tested more
than 1,000 women in Palm Beach County, 875 of whom had never had a mammogram.
With much of the funds raised this year, the Kathryn Krickstein Pressel
MammoVan continues providing affordable and …. Original source  : St. Andrews Country Club of Boca Raton Members Team With Morgan Pressel to Raise $502,000 to Fight Breast Cancer.